Serum Magnesium, Outcomes, and the Effect of Empagliflozin in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
- DOI
- 10.1016/j.jchf.2025.102889
- Published
- 2026-02
- Container
- JACC: Heart Failure
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jchf.2025.102889,
title = {Serum Magnesium, Outcomes, and the Effect of Empagliflozin in Heart Failure With Mildly Reduced and Preserved Ejection Fraction},
author = {João Pedro Ferreira and Milton Packer and Javed Butler and Francisco Vasques-Nóvoa and Pedro Marques and Stuart Pocock and Gerasimos Filippatos and Faiez Zannad and Stefan D. Anker},
year = {2026},
journal = {JACC: Heart Failure},
doi = {10.1016/j.jchf.2025.102889},
url = {https://doi.org/10.1016/j.jchf.2025.102889}
}RIS
TY - JOUR TI - Serum Magnesium, Outcomes, and the Effect of Empagliflozin in Heart Failure With Mildly Reduced and Preserved Ejection Fraction AU - João Pedro Ferreira AU - Milton Packer AU - Javed Butler AU - Francisco Vasques-Nóvoa AU - Pedro Marques AU - Stuart Pocock AU - Gerasimos Filippatos AU - Faiez Zannad AU - Stefan D. Anker PY - 2026 JO - JACC: Heart Failure DO - 10.1016/j.jchf.2025.102889 UR - https://doi.org/10.1016/j.jchf.2025.102889 ER -
APA
Ferreira, J. P., Packer, M., Butler, J., Vasques-Nóvoa, F., Marques, P., Pocock, S., Filippatos, G., Zannad, F., & Anker, S. D. (2026). Serum Magnesium, Outcomes, and the Effect of Empagliflozin in Heart Failure With Mildly Reduced and Preserved Ejection Fraction. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2025.102889
Source records
- crossref · retrieved 2026-09-26T10:06:05.394Z